Transcode Therapeutics, Inc. (RNAZ) income statement
RNAZNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.16−0.14 (-10.77%)
Close on Nov 20, 2026Market cap $1.17MP/E –Yield –
Transcode Therapeutics, Inc. financial ratios
See a number that looks wrong?